Navigation Links
Crescendo Biologics Announces First 'Triple Knockout' Mouse
Date:9/29/2010

d=repstate&site=23818417&&ver=1&imageUrl=http://content.prnewswire.com/designimages&skill=PRN' id="chatimage" border="0" style="display:none;" > --> Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services, Clinical Trials & Medical Discoveries Click to view news release full screen  

Crescendo Biologics Announces First 'Triple Knockout' Mouse

 

CAMBRIDGE, England, September 29, 2010 /PRNewswire/ --

- Mice Lacking Endogenous Antibody Polypeptides Offer Powerful New Tool for Antibody Fragment Development

Crescendo Biologics Limited (Crescendo) today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.

This is a significant advance over previous knockout
'/>"/>

SOURCE Crescendo Biologics Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
2. Immune Biosimilars Will Erode $10.8 Billion in Immune Biologics Brand Sales in 2019 Across the U.S., EU5 and Japan
3. Edimer Pharmaceuticals and CMC Biologics Announce Agreement to Manufacture EDI200 Recombinant Protein
4. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
5. Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential
6. Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage
7. Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation and the Addition of Board Member, Mark Spilker
8. Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
9. In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market
10. Dendreon Completes Submission of Biologics License Application for PROVENGE
11. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Norris, TN (PRWEB) September 16, 2014 ... several new initiatives to position themselves for ... capabilities for labeling and encoding, Pharma Packaging ... adding new hardware and software and new ... on current Good Manufacturing Practices (cGMP), Pharma ...
(Date:9/16/2014)... 2014 Convoy Therapeutics, Inc., a ... products to treat patients directly at the site ... SPACE™ Technology Platform announced today that John Muraski, ... at the White Hat Life Science Investor Conference™ ... Phoenix. In addition, interested individuals can meet ...
(Date:9/16/2014)... , Sept. 16, 2014  LABSCO, the leading ... products to hospitals, physician office laboratories and alternate ... October 1, 2014, it will serve as Siemens ... market segments and as a semi-exclusive sales distributor ... contiguous United States . LABSCO ...
(Date:9/16/2014)... , Sept. 16, 2014 /PRNewswire-iReach/ -- Researchers found ... test identifies patients with bone fragility fracture when ... million people worldwide are at risk of fracture ... standard bone strength test, the DEXA bone density ... Society for Bone and Mineral Research Annual Conference ...
Breaking Biology Technology:Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 3
... May 25, 2011 SuperNova Diagnostics®, Inc., a ... health applications, today announced it has been selected ... Startup Entrepreneurs (SVASE) annual Launch: Silicon Valley 2011 ... June 7, 2011 at 1:15 p.m. PDT.  The ...
... 25, 2011 Otonomy, Inc., a ... diseases and disorders of the inner and middle ... as the company,s chief operations officer.  Mr. Wroblewski ... areas of manufacturing, product supply chain management, packaging ...
... (NPL), in collaboration with Linkping University, Sweden, have shown ... easily identified in ambient conditions using Electrostatic Force Microscopy ... only applicable to the material that consists of one ... of any number of layers is possible, the thicker ...
Cached Biology Technology:SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011 2Otonomy Appoints Gerald Wroblewski as Chief Operations Officer 2Otonomy Appoints Gerald Wroblewski as Chief Operations Officer 3
(Date:9/15/2014)... evolution experiment scientists from GEOMAR Helmholtz Centre for ... Sea Fisheries have demonstrated for the first time, ... the world,s oceans, Emiliania huxleyi , can ... temperatures. In their study, the researchers found no ... to these two aspects of climate change would ...
(Date:9/15/2014)... that the proteins in our cells cooperate with one ... tens of thousands of different proteins find the correct ... human body, brain and nervous system. A recent breakthrough ... busted down the door and provided a look at ... , Professor emeritus Jens Jrgen Led of the University ...
(Date:9/15/2014)... September 15, 2014: Globally, cardiovascular disease (CVD) claims 17 ... pressure take an additional 9.4 million. 1 New ... Fed Lipid Congress in Montpellier, France on September 15, ... a beneficial role. , At the Milk ... association between milk and risk for hypertension and CVD ...
Breaking Biology News(10 mins):Small algae with great potential 2Small algae with great potential 3Protein courtship revealed through chemist's lens 2Protein courtship revealed through chemist's lens 3Dairy consumption linked to lower blood pressure and cardiovascular disease risk 2
... recognition of her ongoing support of the nation,s human ... 2012 recipient of the National Space Biomedical Research Institute,s ... was honored today during the official opening of a ... Baylor College of Medicine,s Center for Space Medicine (CSM). ...
... Wildlife Conservation Society, the ARC Centre for Excellence ... more than 40 coral reefs in the Indian ... between local communities, conservation groups, and governmentsprovides one ... The finding is the outcome of the largest ...
... ColdQuanta Inc. of Boulder and the University of Colorado ... physics research developed by CU-Boulder and SRI International. The ... new form of matter created just above absolute zero. ... be used to dramatically increase the performance of devices ...
Cached Biology News:Space research institute honors Sen. Hutchison with Pioneer Award 21 solution to global overfishing found 21 solution to global overfishing found 3Ultracold matter technology from CU and SRI International licensed to Boulder's ColdQuanta 2
... new Adept CE 4100 high pressure ... flow precision, with software drive compensation, reducing ... 0.001-10mL/min are selectable in 0.001mL steps. , ... inert and bio-compatible., Pumps may be programmed ...
... The CHEF-DR III variable angle system, 220-240 ... greater than 6 Mb DNA fragments by pulsed ... electrophoresis cell, power module, variable-speed pump, 14 x ... comb holder, 15-well, 1.5 mm thick comb, screened ...
... membrane and filter paper sandwiches are composed ... two sheets of thick filter paper that ... filter paper sandwich. These 7 x 8.5 ... immunoblotting fit Ready Gel-sized gels and are ...
... Antibiotic isolated fromStreptomyces griseolusthat inhibits ... transferase activity in eukaryote ribosomes. Reported ... of cells including promyelocytic leukemia cells, ... adenocarcinoma cells. Initiates intracellular signals and ...
Biology Products: